Basics Avidity Biosciences, Inc. IPO Date: June 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $7.15B Activated in VL: True Average Daily Range Avg Daily Range: $0.76 | 3.27% Avg Daily Range (30 D): $1.37 | 3.09% Avg Daily Range (90 D): $1.07 | 2.66% Institutional Daily Volume Avg Daily Volume: .79M Avg Daily Volume (30 D): 2.36M Avg Daily Volume (90 D): 2.24M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 2,798 Avg Inst. Trade: $3.12M Avg Inst. Trade (30 D): $6.48M Avg Inst. Trade (90 D): $4.65M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.38M Avg Closing Trade (30 D): $20.78M Avg Closing Trade (90 D): $12.63M Avg Closing Volume: 161.45K     News Jul 1, 2024 @ 5:38 PM Top Performing Industry ETFs In June: Software Lea... Source: Piero Cingari Jun 13, 2024 @ 2:39 PM Avidity (RNA) Up 33% on Rare Muscle Disease Study ... Source: Zacks Equity Research Jun 10, 2024 @ 12:01 PM A Glimpse Into The Expert Outlook On Avidity Biosc... Source: Benzinga Insights May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 9, 2024 @ 9:15 PM Coherus BioSciences (CHRS) Reports Q1 Loss, Misses... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.21 $-.9 Diluted EPS $-1.21 $-.9 Revenue $ $ 3.85M $ 1.57M Gross Profit $ $ $ Net Income / Loss $ $ -157.32M $ -115.77M Operating Income / Loss $ $ -171.14M $ -131.52M Cost of Revenue $ $ $ Net Cash Flow $ $ -10.29M $ 34.34M PE Ratio